Extraocular motility and alignment testing was within normal limits
Investigators to bring data on glucose management with oral orforglipron Julio Rosenstock, MD, Francesco Giorgino, MD, PhD, and other panelists will discuss results from the ACHIEVE clinical trials, including ACHIEVE-3, which compared oral semaglutide and orforglipron for use in type 2 diabetes.
Safety Profile: Preclinical data indicate a wide safety margin for BPC-157 (no lethal dose up to ~20 mg/kg)
The Soul: NLP and hypnotherapy for addressing emotional eating patterns and self-sabotage
Chickpeas : High in fiber and prebiotics
This trial is for adults with a BMI of 25 kg/m2 who meet the criteria for Cocaine Use Disorder, have used cocaine recently (confirmed by urine test), and can provide informed consent